News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,375 Results
Type
Article (40429)
Company Profile (292)
Press Release (654654)
Section
Business (205073)
Career Advice (2023)
Deals (35547)
Drug Delivery (90)
Drug Development (81403)
Employer Resources (168)
FDA (16219)
Job Trends (14941)
News (346771)
Policy (32823)
Tag
Academia (2571)
Alliances (49673)
Alzheimer's disease (1300)
Approvals (16182)
Artificial intelligence (161)
Bankruptcy (362)
Best Places to Work (11696)
Biotechnology (204)
Breast cancer (207)
Cancer (1531)
Cardiovascular disease (122)
Career advice (1689)
CAR-T (107)
Cell therapy (314)
Clinical research (65233)
Collaboration (568)
Compensation (307)
COVID-19 (2675)
C-suite (133)
Data (1468)
Diabetes (192)
Diagnostics (6249)
Earnings (85145)
Employer resources (146)
Events (111229)
Executive appointments (486)
FDA (16994)
Funding (516)
Gene therapy (214)
GLP-1 (634)
Government (4444)
Healthcare (18955)
Infectious disease (2774)
Inflammatory bowel disease (115)
Interviews (315)
IPO (16425)
Job creations (3661)
Job search strategy (1437)
Layoffs (425)
Legal (7931)
Lung cancer (228)
Manufacturing (216)
Medical device (13315)
Medtech (13320)
Mergers & acquisitions (19381)
Metabolic disorders (502)
Neuroscience (1664)
NextGen: Class of 2025 (6566)
Non-profit (4546)
Northern California (1872)
Obesity (285)
Opinion (194)
Patents (134)
People (57090)
Phase I (20315)
Phase II (28707)
Phase III (21427)
Pipeline (614)
Postmarket research (2574)
Preclinical (8612)
Radiopharmaceuticals (242)
Rare diseases (285)
Real estate (5941)
Regulatory (22005)
Research institute (2340)
Resumes & cover letters (352)
Southern California (1616)
Startups (3610)
United States (16695)
Vaccines (611)
Weight loss (199)
Date
Today (121)
Last 7 days (401)
Last 30 days (1970)
Last 365 days (35038)
2025 (1720)
2024 (35439)
2023 (40256)
2022 (51404)
2021 (56008)
2020 (54594)
2019 (46918)
2018 (35360)
2017 (32315)
2016 (31768)
2015 (37803)
2014 (31593)
2013 (26642)
2012 (28859)
2011 (29529)
2010 (27636)
Location
Africa (743)
Arizona (203)
Asia (38001)
Australia (6183)
California (4253)
Canada (1555)
China (364)
Colorado (190)
Connecticut (205)
Europe (81146)
Florida (607)
Georgia (147)
Illinois (416)
Indiana (242)
Maryland (700)
Massachusetts (3292)
Michigan (183)
Minnesota (318)
New Jersey (1186)
New York (1205)
North Carolina (798)
Northern California (1872)
Ohio (155)
Pennsylvania (1000)
South America (1114)
Southern California (1616)
Texas (618)
Utah (119)
Washington State (430)
695,375 Results for "emergent biosolutions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
Emergent BioSolutions Inc. announced that it has entered into a “Consent, Waiver and Seventh Amendment” to its existing credit facility.
April 30, 2024
·
2 min read
Business
Emergent BioSolutions Reports First Quarter 2024 Financial Results
Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the first quarter ended March 31, 2024.
May 1, 2024
·
31 min read
Press Releases
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
January 14, 2025
·
10 min read
Deals
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million
Emergent BioSolutions Inc. announced that it has entered into a definitive agreement to sell its drug product facility in Baltimore-Camden to an affiliate of Bora Pharmaceuticals Co., Ltd., a leading international pharmaceutical services company, for a total value of approximately $30 million.
June 20, 2024
·
4 min read
Press Releases
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
January 8, 2025
·
1 min read
Press Releases
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)
January 8, 2025
·
5 min read
BioCapital
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
Emergent BioSolutions Inc. announced that its 2024 Annual Meeting of Stockholders will be held in a virtual-only format via live audio webcast on Thursday, May 23, 2024 at 9:00 am eastern time.
May 10, 2024
·
1 min read
Press Releases
Emergent BioSolutions Reports Third Quarter 2024 Financial Results
November 7, 2024
·
41 min read
Policy
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
Emergent BioSolutions Inc. announced that the U.S. Food and Drug Administration has listed “No Action Indicated” or NAI status classification for the company’s Baltimore Bayview manufacturing facility.
March 25, 2024
·
3 min read
Business
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the quarter and year ended December 31, 2023.
March 6, 2024
·
39 min read
1 of 69,538
Next
